SU65. Neural Adaptation Differences among Psychosis Biotypes

Matthew E. Hudgens-Haney,Lauren K. Hayrynen,Matcheri S. Keshavan,Godfrey D. Pearlson,Carol A. Tamminga,John A. Sweeney,Brett A. Clementz

DOI: https://doi.org/10.1093/schbul/sbx024.063

2017-01-01

Schizophrenia Bulletin

Abstract:Background: Schizophrenia, schizoaffective disorder, and psychotic bipolar disorder may have distinct and shared neurophysiological indicators of disease risk, although a psychosis continuum model accounts best for neurobiological data when groups are defined by DSM diagnoses. Previous B-SNIP data, however, document 3 distinct psychosis Biotypes with unique neurobiological features not accounted for by a continuum of severity model. Disrupted sensory processing is a core feature of psychotic disorders and is likely a major contributor to associated cognitive impairments. This study investigated plasticity of sensory-attentional processing. Deviations in these neurobiological features are better captured by biotype designations than a psychosis continuum. Methods: EEG was collected while healthy individuals (N = 221) and psychosis probands (N = 455) were administered auditory oddball (OB) and paired stimuli (PS) tasks. Complex responses evoked by these tasks exhibit amplitude changes with tone repetition in healthy individuals, indexing sensorineural plasticity mechanisms. Adaptation to repetition was assessed by comparing neural responses to early, middle, and late trials (eg, the 150 OB trials were analyzed as 3 sets of 50 trials). Analyses were calculated using 2 psychosis subgrouping systems: (1) Biotypes and (2) Schizo-Bipolar Scale (SBS), a psychosis continuum scale. Results: Clinical-based subgroupings revealed lower amplitude neural responses than healthy individuals for both tasks. A minority of ERP components discriminated SBS subgroups, though not in a consistent pattern. Likewise, neural adaptation effects were largely similar across SBS groups. Biotype-based subgroups however show a number of differences. Biotypes differed drastically in overall neural response amplitudes, with Biotype 1 being the most impaired, Biotype 2 showing the greatest amplitude and often not differing from healthy, and Biotype 3 showing slightly lesser amplitude than Biotype 2. Trial repetition analyses revealed differences in the extent of neural adaptation, with Biotype 1 showing little change over time. Further, biotypes differed on adaption functions. Biotype 3, like the healthy group, showed a much larger decrease between early and middle trials than between middle and late trials. In contrast, Biotype 2 often showed a steady amplitude decrease over time. Conclusion: Our findings using clinical symptom-based subgrouping suggest that while auditory disruptions may differ slightly according to psychosis severity, these differences are inconsistent and do not extent to neural adaptation mechanisms. Biotypes, however, revealed subgroup differences in overall neural response levels, the extent of neural adaptation, and the rate at which adaptation occurs. These findings provide support for neurobiological heterogeneity in brain plasticity not accounted for by clinical symptomatology.